PCT/2001/50 - World Intellectual Property Organization
PCT/2001/50 - World Intellectual Property Organization
PCT/2001/50 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>50</strong>/<strong>2001</strong><br />
22792 <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 13 Dec/déc <strong>2001</strong><br />
(51) 7 A61K 31/00<br />
(11) WO 01/93852<br />
(21) <strong>PCT</strong>/US01/18901<br />
(13) A2<br />
(22) 8 Jun/juin <strong>2001</strong> (08.06.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 60/210,367 9 Jun/juin 2000<br />
(09.06.2000)<br />
US<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) METHOD OF TREATING PAIN USING<br />
NALBUPHINE AND OPIOID ANTAGO-<br />
NISTS<br />
PROCEDE DE TRAITEMENT DE LA<br />
DOULEUR EN UTILISANT LA NAL-<br />
BUPHINE ET DES ANTAGONISTES<br />
OPIOIDES<br />
(71) THE REGENTS OF THE UNIVERSITY<br />
OF CALIFORNIA [US/US]; Office of Technology<br />
Management, University of California,<br />
1294 9th Ave., Suite 1, Box 1209, Room<br />
204, San Francisco, CA 94143-1209 (US).<br />
(72) LEVINE, Jon, D.; 791 12th Avenue, San<br />
Francisco, CA 94118 (US).<br />
(74) ACKERMAN, Joel, G. et al. / etc.;<br />
Townsend and Townsend and Crew LLP,<br />
Two Embarcadero Center, Eight Floor, San<br />
Francisco, CA 94111 (US).<br />
(81) AU CA JP.<br />
(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE TR).<br />
(51) 7 A61K 31/10, 31/045, A23K 1/00, 1/30<br />
(11) WO 01/93853 (13) A1<br />
(21) <strong>PCT</strong>/US01/17705<br />
(22) 1 Jun/juin <strong>2001</strong> (01.06.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 09/586,075 2 Jun/juin 2000 US<br />
(02.06.2000)<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) MANAGEMENT OF SNORING<br />
BY ORAL ADMINISTRATION OF<br />
DIMETHYL SULFONE<br />
TRAITEMENT DU RONFLEMENT PAR<br />
ADMINISTRATION PAR VOIE ORALE<br />
DE SULFONE DE DIMETHYLE<br />
(71) ELSTAN CORPORATION [US/US]; 1055<br />
S.W. Westwood Court, Portland, OR 97201<br />
(US).<br />
(72) JACOB, Stanley, W.; 1055 Southwest Westwood<br />
Court, Portland, OR 97201 (US).<br />
(74) MARTIN, Timothy, J. et al. / etc.; Timothy<br />
J. Martin, P.C., 92<strong>50</strong> W. 5th Avenue, Suite<br />
200, Lakewood, CO 80226 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EE ES FI GB GD GE GH GM HR<br />
HU ID IL IN IS JP KE KG KP KR KZ LC<br />
LK LR LS LT LU LV MA MD MG MK MN<br />
MW MX MZ NO NZ PL PT RO RU SD SE<br />
SG SI SK SL TJ TM TR TT TZ UA UG UZ<br />
VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 31/155<br />
(11) WO 01/93854 (13) A1<br />
(21) <strong>PCT</strong>/US01/40874<br />
(22) 7 Jun/juin <strong>2001</strong> (07.06.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 60/210,114 7 Jun/juin 2000 US<br />
(07.06.2000)<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) METHOD FOR TREATING HYPER-<br />
GLYCEMIA<br />
PROCEDE DE TRAITEMENT DE L’HY-<br />
PERGLYCEMIE<br />
(71) ALTEON, INC. [US/US]; 170 Williams<br />
Drive, Ramsey, NJ 07446 (US).<br />
(72) WUERTH, Jean-Paul; 15 Peacock Path,<br />
P.O. Box 1697, Quogue, NY 11956 (US).<br />
CARTWRIGHT, Kenneth; 157 Round Hill<br />
Road, P.O. Box 162, Blooming Grove, NY<br />
10914 (US).<br />
(74) JACKSON, Arthur, E.; Dechert, P.O. Box<br />
5218, Princeton, NJ 08543 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EE ES FI GB GD GE GH GM HR<br />
HU ID IL IN IS JP KE KG KP KR KZ LC<br />
LK LR LS LT LU LV MA MD MG MK MN<br />
MW MX MZ NO NZ PL PT RO RU SD SE<br />
SG SI SK SL TJ TM TR TT TZ UA UG UZ<br />
VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/164, 31/198, A23L 1/30, A61P<br />
17/16 // A61K 7/00<br />
(11) WO 01/93855<br />
(21) <strong>PCT</strong>/JP01/04764<br />
(13) A1<br />
(22) 6 Jun/juin <strong>2001</strong> (06.06.<strong>2001</strong>)<br />
(25) ja (26) ja<br />
(30) 2000-170388 7 Jun/juin 2000<br />
(07.06.2000)<br />
JP<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) SKIN-MOISTENING COMPOSITIONS<br />
AND SKIN-MOISTENING FOODS<br />
COMPOSITIONS ET ALIMENTS HY-<br />
DRATANTS<br />
(71) OTSUKA KAGAKU KABUSHIKI<br />
KAISHA [JP/JP]; 2-27, Otedori 3-chome,<br />
Chuo-ku, Osaka-shi, Osaka 540-0021 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) OKAYAMA, Kenichi [JP/JP]; c/o OT-<br />
SUKA KAGAKU KABUSHIKI KAISHA,<br />
2-27, Otedori 3-chome, Chuo-ku, Osaka-shi,<br />
Osaka 540-0021 (JP). YOSHIDA,<br />
Harumi [JP/JP]; c/o OTSUKA KAGAKU<br />
KABUSHIKI KAISHA, 2-27, Otedori<br />
3-chome, Chuo-ku, Osaka-shi, Osaka<br />
540-0021 (JP).<br />
(74) FUJIMOTO, Noboru et al. / etc.; Nagahori<br />
Community Bldg. 4F, 5-8, Minami-senba<br />
2-chome, Chuoh-ku, Osaka-shi, Osaka<br />
542-0081 (JP).<br />
(81) JP US.<br />
(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE TR).<br />
(51) 7 A61K 31/167, 31/245, 33/06, 9/08, A61P<br />
1/00, 23/02, 43/00<br />
(11) WO 01/93856 (13) A1<br />
(21) <strong>PCT</strong>/JP01/04720<br />
(22) 5 Jun/juin <strong>2001</strong> (05.06.<strong>2001</strong>)<br />
(25) ja (26) ja<br />
(30) 2000-168<strong>50</strong>2 6 Jun/juin 2000 JP<br />
(06.06.2000)<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) MEDICAL COMPOSITION KIT FOR<br />
TREATING LESIONED ABNORMAL<br />
TISSUE<br />
KIT DE COMPOSITION MEDICALE<br />
DESTINE A TRAITER UN TISSU<br />
ANORMAL LESE<br />
(71) LEQUIO PHARMA CO., LTD. [JP/JP];<br />
1-12, Matsuyama 2-chome, Naha-shi, Okinawa<br />
900-0032 (JP). WELFIDE COR-<br />
PORATION [JP/JP]; 6-9, Hiranomachi<br />
2-chome, Chuo-ku, Osaka-shi, Osaka<br />
541-0046 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) OKU, Kinuko [JP/JP]; <strong>50</strong>1, Shatoo-Kume,<br />
23-21, Kume 2-chome, Naha-shi,<br />
Okinawa 900-0033 (JP). IWAMOTO,<br />
Takako [JP/JP]; c/o WELFIDE CORPORA-<br />
TION Drug Development Laboratories, 955,<br />
Oaza Koiwai, Yoshitomimachi, Chikujo-gun,<br />
Fukuoka 871-0801 (JP). ONO, Takashi<br />
[JP/JP]; c/o WELFIDE CORPORATION<br />
Drug Development Laboratories, 955, Oaza<br />
Koiwai, Yoshitomimachi, Chikujo-gun,<br />
Fukuoka 871-0801 (JP).<br />
(74) SHOJI, Takashi; 6F, SN Iwamotocho Bldg.,<br />
2-10, Iwamotocho 3-chome, Chiyoda-ku,<br />
Tokyo 101-0032 (JP).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PL PT RO RU SD<br />
SE SG SI SK SL TJ TM TR TT TZ UA UG<br />
US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/19, A61P 17/02, A61K 9/107<br />
(11) WO 01/93857<br />
(21) <strong>PCT</strong>/CA01/00843<br />
(13) A1<br />
(22) 8 Jun/juin <strong>2001</strong> (08.06.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 09/590,819 9 Jun/juin 2000<br />
(09.06.2000)<br />
US<br />
(43) 13 Dec/déc <strong>2001</strong> (13.12.<strong>2001</strong>)<br />
(54) COMPOSITION FOR PAIN MEDI-<br />
ATION AND APPARATUS AND<br />
METHOD OF USE THEREOF<br />
COMPOSITION POUR LA MEDIA-<br />
TION DE LA DOULEUR, PROCEDE ET<br />
APPAREIL PERMETTANT L’UTILISA-<br />
TION DE CETTE COMPOSITION